Image de couverture de livre

Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Qi Liu, Amita Joshi, Joseph F. Standing, Piet H. van der Graaf
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Clinical Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Innovations in Clinical Pharmacology: Shaping the Future of Evidence Generation in Research, Development, and Utilization of Medicines
par: Karthik Venkatakrishnan, et autres
Publié: (2025)

Progress in Clinical Pharmacology in China: A Randomized Controlled Study to Advance Genotype‐Guided Precision Medicine
par: Liang Zhao, et autres
Publié: (2024)

Getting the Dosage Right: A Vital Role for Clinical Pharmacology in the Era of Precision Medicine
par: Iris K. Minichmayr, et autres
Publié: (2024)

Progress in Clinical Pharmacology in China: An Ongoing Evolution
par: Liang Zhao, et autres
Publié: (2025)

History and Evolution of Innovations in Clinical Pharmacology
par: Lawrence J. Lesko, et autres
Publié: (2025)

Best Practices for Pharmacokinetic Studies of New Chemical Entities
par: Ya‐Feng Wen, et autres
Publié: (2024)

Interchanging Biosimilars Using Proteomics
par: Piet H. van der Graaf, et autres
Publié: (2025)

Weaning off ThoroughQTStudies
par: Mai Mehanna, et autres
Publié: (2024)

Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development
par: Georgi I. Kapitanov, et autres
Publié: (2025)

Reflections on Model‐Informed Drug Development
par: Lawrence J. Lesko, et autres
Publié: (2024)

Quantitative Systems Pharmacology‐Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease
par: Chanchala Kaddi, et autres
Publié: (2024)

Moving the Needle for Oncology Dose Optimization: A Call for Action
par: Karthik Venkatakrishnan, et autres
Publié: (2024)

Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV : An Emerging Frontier for Clinical Pharmacology
par: Aaron S. Devanathan, et autres
Publié: (2025)

Model‐Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC : A QSP Model for Alpelisib and Tipifarnib Combination
par: Jaehee Shim, et autres
Publié: (2026)

Balancing Reassurance and Vigilance: Real‐World Evidence in Post‐Marketing Drug Safety
par: Yow‐Ming C. Wang, et autres
Publié: (2026)

Model‐Informed Precision Dosing Using Machine Learning for Levothyroxine in General Practice: Development, Validation and Clinical Simulation Trial
par: Jules M. Janssen Daalen, et autres
Publié: (2024)

The Future of Clinical Translational Pharmacology
par: Matthew L. Rizk, et autres
Publié: (2026)

Machine Learning and Artificial Intelligence in PK‐PD Modeling: Fad, Friend, or Foe?
par: Zhonghui Huang, et autres
Publié: (2024)

Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins
par: Yow‐Ming C. Wang, et autres
Publié: (2024)

New Horizons for Clinical Pharmacology & Therapeutics : Global Outreach for Optimal Patient Outcomes
par: Karen Rowland Yeo
Publié: (2025)

American Society for Clinical Pharmacology and Therapeutics
Publié: (2026)

Optimizing Clinical Translation of Bispecific T‐cell Engagers through Context Unification with a Quantitative Systems Pharmacology Model
par: Xiaozhi Liao, et autres
Publié: (2024)

The Role for Clinical Translational Pharmacology in Advancing Pharmacoequity
par: Sonya Tang Girdwood, et autres
Publié: (2025)

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T‐Cell Engagers Development in Oncology
par: Mohamed Elmeliegy, et autres
Publié: (2024)

HIV Pharmacology Data Repository: Setting the New Information‐Sharing Standard for Clinical and Preclinical Pharmacokinetic Studies
par: Lauren A.R. Tompkins, et autres
Publié: (2025)

Emergence of Small Nucleic Acids as Drugs in Precision Medicine
par: Xing Cheng, et autres
Publié: (2025)

Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
par: John D. Davis, et autres
Publié: (2024)

Clinical Pharmacology Considerations for the “Off‐the‐Shelf” Allogeneic Cell Therapies
par: Hardik Mody, et autres
Publié: (2024)

Seasons of Growth: Reflections on the CPT Editor‐in‐Training Program
par: Matthijs W. van Hoogdalem, et autres
Publié: (2025)

Clinical Pharmacology Strategies for Bispecific Antibody Development: Learnings from FDA‐Approved Bispecific Antibodies in Oncology
par: KyoungSoo Lim, et autres
Publié: (2024)

From Global Impact to Pharmacoequity: A Call to Action for Clinical Pharmacology
par: Karen Rowland Yeo, et autres
Publié: (2026)

Correction to “Clinical Pharmacology and Translational Considerations in the Development of CRISPR‐Based Therapies”
Publié: (2025)

Clinical Pharmacology Quality Assurance Program for Global HIV and Co‐Infection Drug Development
par: Robin DiFrancesco, et autres
Publié: (2026)

Machine Learning Prediction of Unbound Ceftriaxone Concentrations in Children: Capturing Developmental Changes in Protein Binding for Precision Dosing
par: Bo‐Hao Tang, et autres
Publié: (2026)

Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and Opportunities
par: Alicia Curth, et autres
Publié: (2024)

Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
par: Ting Wang, et autres
Publié: (2025)

Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
par: Prathap Nagaraja Shastri, et autres
Publié: (2024)

Impact of COVID‐19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective
par: Mohamed‐Eslam F. Mohamed, et autres
Publié: (2024)

Reply to: “Current Use of PBPK Modeling in New Medicinal Product Approvals at EMA: A Clinical Appraisal of Voclosporin in Lupus Nephritis”
par: Polly Paul, et autres
Publié: (2025)

Leading the Way: Multi‐Drug Resistance Protein (MDR1) and Clinical Pharmacology—Commentary on Kim et al.
par: Kathleen M. Giacomini
Publié: (2025)